Transcatheter Closure of Atrial Septal Defect Associated With Pulmonary Artery Hypertension using Fenestrated Devices

JOU-KOU WANGSHUENN-NAN CHIUMING-TAI LINCHUN-AN CHENCHUN-WEI LUMEI-HWAN WU2021-06-112021-06-1120210002-9149https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102779178&doi=10.1016%2fj.amjcard.2021.01.025&partnerID=40&md5=1e0cb1f588c761ad8433d9fae592aa6ehttps://scholars.lib.ntu.edu.tw/handle/123456789/565593In patients with pulmonary artery hypertension (PAH) associated with atrial septal defect (ASD), closure of ASD may carry significant risks. We aimed to evaluate the safety and efficacy of transcatheter closure of ASD in selected patients with PAH using a[SDGs]SDG3sildenafil; vasodilator agent; adolescent; adult; aged; artery catheterization; Article; cardiovascular mortality; comparative study; device safety; disease association; female; follow up; heart atrium septum defect; heart hemodynamics; human; lung arteryTranscatheter Closure of Atrial Septal Defect Associated With Pulmonary Artery Hypertension using Fenestrated Devicesjournal article10.1016/j.amjcard.2021.01.025336674392-s2.0-85102779178